[ad_1]
Kenvue Inc. Tylenol model ache reliever on the market at a pharmacy in New York, US, on Wednesday, March 27, 2024.
Bloomberg | Bloomberg | Getty Photos
Shares of Kenvue fell greater than 10% on Friday after a report that Well being and Human Providers Secretary Robert F. Kennedy Jr. will doubtless hyperlink autism to using the corporate’s ache medicine Tylenol in pregnant ladies.
HHS will launch the report that would draw that hyperlink this month, the Wall Road Journal reported on Friday.
That report will even counsel a medication derived from folate – a water-soluble vitamin – can be utilized to deal with signs of the developmental dysfunction in some folks, in keeping with the Journal.
Tylenol may very well be the newest broadly used and accepted remedy that Kennedy has undermined on the helm of HHS, which oversees federal well being companies that regulate medication and different therapies. Kennedy has additionally taken steps to vary vaccine coverage within the U.S., and has amplified false claims about secure and efficient photographs that use mRNA know-how.
In a press release, Kenvue stated it has “repeatedly evaluated the science and [continues] to consider there is no such thing as a causal hyperlink” between using acetaminophen, the generic identify for Tylenol, throughout being pregnant and autism.
The corporate added that the Meals and Drug Administration and main medical organizations “agree on the protection” of the drug, its use throughout being pregnant and the knowledge supplied on the Tylenol label.
The FDA web site says the company has not discovered “clear proof” that applicable use of acetaminophen throughout being pregnant causes “adversarial being pregnant, start, neurobehavioral, or developmental outcomes.” However the FDA stated it advises pregnant ladies to talk with their health-care suppliers earlier than utilizing over-the-counter medication.
That is breaking information. Please refresh for updates.
[ad_2]
